keyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
Agenda for Day 2 - Friday, September 25th 2026 - ET (Eastern Time, GMT-05:00)
search
Agenda for Day 2 - Friday, September 25th 2026 - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
Networking Break
7:30am - 8:00am
Networking Breakfast
Showing 1 of 1 Streams
General Session
8:00am - 8:05am
Chair's Day One Recap
- Adam S. Mostafa - Chief Financial Officer and Head of Business Development, Sitryx Therapeutics
8:05am - 9:05am
Optimizing ERP Systems: Tools and Strategies for Biotech Growth
- Discover how to apply practical lessons from ERP implementations and transitions to advanced systems as organizations grow
- Explore ways to align ERP tools with company size, operational needs, and cross-departmental IT requirements
- Master the process of selecting and integrating essential software, including equity administration platforms and procurement-to-payment systems
- Uncover strategies to address implementation pain points and optimize post-implementation efficiency and financial reporting accuracy
CPE Credits Available: 1.2
- Kyle Mandala - Life Sciences Enterprise Resource Planning (ERP) Strategy Director, RSM US LLP
- Maggie Berkeley - Biopharma Sector Leader and Risk Advisory Principal, RSM US LLP
- Michelene Taptich - Vice President, Commercial Accounting, Priovant Therapeutics
- Gina Tracey - Vice President, Corporate Controller, Alnylam Pharmaceuticals
9:05am - 10:05am
Biotech Financing Insights: Navigating Dynamic Capital Markets
- Gain insights into today's biotech capital markets from finance leaders who have navigated successful transactions across private equity, public offerings, and strategic partnerships
- Explore real-world lessons from recent transactions, including deal structuring, valuation benchmarks, and creative non-dilutive financing alternatives
- Discover strategies for timing capital raises by balancing clinical milestones, burn rate, and market dynamics to extend runway through critical development stages
- Understand accounting and financial reporting implications of different financing structures
CPE Credits Available: 1.2
- Laura Vasquez - Head of FP&A & Business Operations, Rocket Pharmaceuticals
- Ethan Holdaway - Vice President, Strategic Finance & IR, ProKidney
- Bill Steinkrauss - Chief Financial Officer, ILiAD Biotechnologies
- Neeraj Kumar - Executive Director, General Management and Strategy Finance, Cardiovascular Metabolism and Neuroscience, Novartis
Showing 1 of 1 Streams
Networking Break
10:05am - 10:35am
Networking and Refreshment Break
Showing 1 of 1 Streams
General Session
10:35am - 11:45am
CFO Panel: Redefining Financial Leadership for Organizational Success
- Explore how today's biotech CFOs are transforming their roles to become catalysts for innovation by driving finance function evolution to enable sustainable growth and operational excellence
- Gain unique insights from seasoned CFOs as they share their career journeys, lessons learned and actionable advice for emerging finance leaders
- Engage in dynamic discussions on overcoming industry challenges, fostering team resilience, and leveraging data-driven strategies to maintain a competitive edge in a rapidly evolving business landscape
CPE Credits Available: 1.4
- Kristen Godsoe - Audit Principal, New England Life Science Industry Leader, Baker Tilly
- Justin Renz - Chief Financial Officer, Zevra Therapeutics
- Kathleen Borthwick - Chief Financial Officer, Passage Bio
- Kory Wentworth - Chief Financial Officer, Entrada Therapeutics
- Mark Mullikin - Fractional/Interim CFO for Life Sciences, .
11:45am - 12:45pm
Navigating Clinical Trials Finance: Accruals, Automation and AI Integration
- Delve into the complexities of clinical trial accruals and their critical role in bridging finance for commercial professionals and clinical teams
- Discover how biotech companies are leveraging innovative accounting tools and automated systems to transform budgeting, forecasting, and clinical trial management to reduce risks and improve operational efficiency
- Gain actionable strategies to design processes that anticipate inaccuracies, ensuring accurate accrual recording while maintaining audit readiness
CPE Credits Available: 1.2
- Jennifer Kyle - Founder and CEO, Condor Software
Showing 2 of 2 Streams
Networking Break
Solution Summit
12:45pm - 1:45pm
Networking Luncheon
1:00pm - 1:30pm
Solution Summit
- Dave Messina - Senior Solution Consultant, Sage Software
Showing 1 of 1 Streams
General Session
1:45pm - 2:45pm
AI in Action: Practical Use Cases Transforming Biotech Finance Operations
This dynamic session will feature use case presentations from biotech professionals, each highlighting a unique, real-world example and outcome of AI application and adaptation strategies to improve efficiency and productivity in finance and operations.
- Explore how AI is transforming workflows in forecasting, GTN operations, clinical approval, and expense reporting
- Learn how AI adoption impacts financial reporting accuracy and strategies to address compliance concerns, including IP leakage, data security, and audit implications of AI adoption
- Discover how AI enables predictive finance models, driving proactive decision-making and operational agility
CPE Credits Available: 1.2
- Jessica Marenco - Associate Director, Accounting Operations, Roivant Sciences
- Soufiane Younoussi - Corporate Controller, BPGbio
2:45pm - 3:45pm
Mastering Capital Allocation: Strategies for Successful Commercialization and Product Launches
- Explore real-world strategies for balancing capital allocation across R&D, commercialization, and portfolio management
- Learn best practices for managing costs, optimizing resources and scaling operations in today’s funding environment
- Gain practical tools and frameworks to make smarter financial decisions and ensure successful commercialization outcomes
CPE Credits Available: 1.2
- Melissa Bradford-Klug - Chief Financial & Business Officer, NorthSea Therapeutics
- Nikita Mody-Patel - Executive Director, FP&A, Moderna Therapeutics
3:45pm - 3:50pm
Chair's Closing Remarks & Close of Conference
- Adam S. Mostafa - Chief Financial Officer and Head of Business Development, Sitryx Therapeutics
